Synthetic Heterocyclic Derivatives as Kinase Inhibitors Tested for the Treatment of Neuroblastoma †

In the last few years, small molecules endowed with different heterocyclic scaffolds have been developed as kinase inhibitors. Some of them are being tested at preclinical or clinical levels for the potential treatment of neuroblastoma (NB). This disease is the most common extracranial solid tumor i...

Descripción completa

Detalles Bibliográficos
Autores principales: Musumeci, Francesca, Cianciusi, Annarita, D’Agostino, Ilaria, Grossi, Giancarlo, Carbone, Anna, Schenone, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658969/
https://www.ncbi.nlm.nih.gov/pubmed/34885651
http://dx.doi.org/10.3390/molecules26237069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658969/
https://www.ncbi.nlm.nih.gov/pubmed/34885651
http://dx.doi.org/10.3390/molecules26237069

Ejemplares similares